In a number of contexts, and particularly in response to cellular stress, stimulation of the NF-kappaB (NF-jB) pathway promotes apoptosis. One mechanism underlying this pro-apoptotic activity is nucleolar sequestration of RelA, which is reported to cause cell death by repressing NF-jB-driven transcription. Here, we identify a novel and distinct nucleolar activity of RelA that induces apoptosis. We demonstrate, using a viral nucleolar localization signal (NoLS)-RelA fusion protein, that direct targeting of RelA to the nucleolus mediates apoptosis, independent of NF-jB transcriptional activity. We demonstrate a requirement for nucleophosmin (NPM, B23.1) in this apoptotic effect, and the apoptotic effect of stress-induced nucleolar RelA. We show by multiple approaches that nucleolar translocation of RelA is causally involved in the relocalization of NPM from the nucleolus to the cytoplasm and that RelA-induced cytoplasmic NPM mediates apoptosis by facilitating the mitochondrial accumulation of BAX. These data uncover a novel stress-response pathway and mechanism by which RelA promotes apoptosis, independent of its effects on NF-jB transcriptional activity. These findings are relevant to the design of novel anticancer agents that target RelA to this compartment.
The process of apoptosis is of fundamental importance to biological pathways ranging from embryogenesis to ageing and normal tissue homoeostasis to stress response. One group of proteins that have a pivotal role in regulating this process is the NF-kappaB (NF-kB) family of transcription factors. 1, 2 The most common form of NF-kB is RelA(P65)/p50 heterodimers, which are generally retained inert in the cytoplasm by the inhibitor protein, I-kappaB (IkB). 3 Following stimulation of the cell by a variety of agents, IkB is degraded, allowing NF-kB to translocate to the nucleus and bind to the promoter regions of its multiple target genes. 3, 4 Although NF-kB is generally regarded as anti-apoptotic, it is now apparent that in particular contexts, and especially in response to cellular stress, NF-kB acts to promote apoptosis. 2, [5] [6] [7] For instance, hypoxia, ultraviolet radiation-C (UV-C), serum withdrawal and DNA damaging agents require nuclear translocation of RelA/NF-kB complexes for their apoptotic effects. 8 Stimulation of the NF-kB pathway is essential for p53-mediated cell death 9 and expression of RelA alone promotes apoptosis in some cell types. 10 However, despite evidence linking NF-kB to the promotion of apoptosis, the mechanisms underlying this effect have yet to be fully resolved.
One mechanism that has been suggested is the induction of repressive/inactive RelA-NF-kB complexes that mediate apoptosis by actively downregulating NF-kB-dependent, anti-apoptotic gene transcription. 8, 11, 12 We have also suggested that nuclear translocation of NF-kB promotes apoptosis by downregulating NF-kB transcriptional activity. However, we described an alternative mechanism for this repression involving nucleolar sequestration of RelA. 13, 14 We demonstrated that upon stimulation of the NF-kB pathway by specific stresses (including UV-C radiation, serum deprivation, cyclin-dependent kinase 4 inhibition and aspirin/related agents) the RelA component of NF-kB translocates from the cytoplasm to the nucleoplasm and then to the nucleolus. 13, 15 We identified a signal at the N-terminus of RelA (aa [27] [28] [29] [30] that was essential for nucleolar translocation of the protein and, using a dominant negative mutant deleted for this domain (green fluorescent protein (GFP)-RelADNoLS), demonstrated that nucleolar sequestration of RelA is causally involved in the repression of NF-kB-driven transcription and the induction of apoptosis. 13 On the basis of these data, we proposed that, like the active repression model, nucleolar translocation of RelA mediates apoptosis purely through effects on NF-kB transcriptional activity.
In addition to its role in ribosome biogenesis, the nucleolus has an essential role in cell growth, stress response, transcriptional regulation and apoptotic cell death. 16, 17 These multiple functions are achieved by over 4500 proteins that move rapidly and dynamically between this compartment, the nucleoplasm and cytoplasm, dependent on cell conditions. 18 Previous studies have linked stress-induced disruption of nucleoli to the induction of apoptosis 19 and a number of apoptotic regulators are known to localize to this compartment. Therefore, it is highly possible that, in addition to its effects on NF-kB transcriptional activity, nucleolar targeting of RelA mediates apoptosis through modulation of nucleolar pathways. In keeping with this suggestion, we have previously shown that nucleolar translocation of transfected GFP-RelA mediates apoptosis in rela null mouse embryo fibroblasts (MEFs), which do not require basal NF-kB activity to survive. 13 Here, we demonstrate that targeting RelA to the nucleolus mediates apoptosis in the absence of repression of NF-kBdriven transcription. Furthermore, we demonstrate that this apoptosis, and that of stress-induced nucleolar RelA, occurs through relocalization of nucleophosmin (NPM, B23.1) from the nucleolus to the cytoplasm, which in turn facilitates the mitochondrial localization of BAX. These data reveal a novel mechanism by which stimulation of the NF-kB pathway induces cell death and a novel role for RelA, independent of its effects on NF-kB transcriptional activity.
Results
Targeting RelA to the nucleolus. Although RelA has a nucleolar localization signal (NoLS), this is only functional in response to specific stimuli. 13 Therefore, to determine whether RelA mediates apoptosis through direct effects on nucleoli, we generated an NoLS-RelA fusion protein (GFPNoLS RelA), to target RelA to this compartment in the absence of additional, complicating signals ( Figure 1a) . We utilized the NoLS from the HIV-1 Rev protein, as this has been shown to contain one of the most efficient signals for targeting foreign proteins to nucleoli and it is dominant to other NoLSs. 20 Analysis of the subcellular localization of GFPNoLS RelA and controls (GFPNoLS and GFP-RelA) revealed that, in keeping with previous data, GFPNoLS localized predominantly to the nucleolus and GFP-RelA to the cytoplasm (Figure 1b) . It also revealed that GFPNoLS RelA was present in the cytoplasm, nucleoplasm and, in 20.2% of cells, in nuclear bodies ( Figure 1b ). These nuclear bodies colocalized with high-density nuclear bodies in brightfield images and in areas devoid of DAPI staining in fixed cells, which are both recognized to be nucleoli (Figures 1b and c) . They also colocalized with the nucleolar protein, upstream-binding factor (UBF), confirming their nucleolar localization (Figure 1c ).
Although these data indicated the Rev NoLS targets RelA to the nucleolus, in a significant proportion of cells, the fusion protein remained cytoplasmic. As this was probably due to cytoplasmic retention of the RelA portion by IkBa, we postulated that treatment with tumor necrosis factor alpha (TNFa), which mediates the rapid degradation of IkBa, would increase the proportion of cells showing GFPNoLS RelA in nucleoli. However, we found that while the fusion protein became predominantly nuclear in response to TNFa (confirming stimulation of the NF-kB pathway), fewer cells demonstrated nucleolar localization, compared with the nonTNFa-treated population (Figure 1d ). We have previously demonstrated that RelA remains in the nucleoplasm in response to TNFa and we suggested that this is because the cytokine fails to induce the post-transcriptional modifications required for nucleolar targeting of the protein. 21 However, these interesting data would suggest that RelA is actively excluded from the nucleolus in response to TNF, even when fused to the rev NoLS.
Nucleolar translocation of RelA and apoptosis. Having established that the Rev NoLS can target RelA to the nucleolus, we next examined the effects on cellular apoptosis. As treatment with TNF did not increase the number of cells showing GFPNoLS RelA in nucleoli, we reverted to expressing the proteins alone, in the absence of additional stimuli. Using annexin V apoptosis assays, we found that a significantly greater percentage of cells expressing GFPNoLS RelA were apoptotic, compared with cells expressing GFPNoLS or GFP-RelA (Figure 2a ). Similar results were obtained using equivalent dsRedtagged proteins in that the dsRedNoLS RelA fusion protein was present in the nucleolus (Figure 2b ) in 25% of transfected cells and expression of this protein was associated with increased apoptosis (Figure 2c ). Similar results were also obtained using RKO cells in that GFP-
NoLS
RelA localized to the nucleolus (Figure 2d ) and induced a significant increase in apoptosis (Figure 2e ).
To further confirm the association between nucleolar RelA and apoptosis, we utilized Mitotracker assays in which apoptotic cells are identified by the demise of their mitochondrial activity and consequent inability to uptake a mitochondrial dye. Figure 2f clearly demonstrates that nucleolar localization of GFPNoLS RelA is associated with loss of mitochondrial activity, while cytoplasmic localization of the same protein is not. Quantification indicated that significantly fewer cells expressing GFPNoLS RelA in nucleoli were Mitotracker positive, compared with those expressing GFPRelA or GFPNoLS (Figure 2g ). Western blot analysis confirmed that the differential effects of expressing the GFPtagged constructs were not caused by differential expression of the proteins (Figure 2h ), while NF-kB reporter assays ruled out the possibility that the apoptotic effect of expressing GFPNoLS RelA was caused by decreased NF-kB-driven transcription (Figure 2i ).
NPM is required for the pro-apoptotic effects of nucleolar targeting of RelA. The above data would suggest that nucleolar translocation of RelA is directly affecting a nucleolar pathway/protein(s) to mediate apoptosis. One protein of interest is NPM as this has a critical role in the regulation of cell growth and death, can interact with RelA and is critical for the apoptotic effects of UV-C, which causes apoptosis through nucleolar translocation of RelA. 13, [22] [23] [24] Therefore, an siRNA approach was used to investigate the role of NPM in the apoptotic effects of nucleolar targeting of RelA.
We obtained efficient depletion of NPM on siRNA transfection and found that depleting NPM did not significantly affect expression levels (Figure 3a and data not shown) or localization (Figure 3b ) of the GFP-tagged proteins. On examination of apoptosis, we found that depletion of NPM had a pro-apoptotic effect alone (data not shown). However, Nucleolar RelA-NPM-BAX: a novel pathway to apoptosis N Khandelwal et al relative to this basal level of apoptosis, the apoptotic effects of expressing GFPNoLS RelA, observed in control siRNA-transfected cells, were completely abrogated in cells transfected with NPM siRNA (Figure 3c ). RelA-mediated NF-kB-driven transcription, although this depletion abrogated apoptosis (Figure 3d ). Taken together, these data suggest that the apoptotic effects of expressing GFPNoLS RelA are independent of NF-kB transcriptional activity and are mediated through NPM.
NPM is required for the pro-apoptotic effects of stimulusinduced nucleolar translocation of RelA. Given that the above system for nucleolar targeting of RelA is experimental, we next examined the requirement for NPM in the proapoptotic effects associated with stress-induced nucleolar translocation of endogenous RelA. We used aspirin as a model NF-kB stimulus as this requires nucleolar translocation of RelA for its pro-apoptotic activity. [13] [14] [15] Western blot analysis indicated NPM siRNA efficiently reduced expression of the protein in the presence and absence of aspirin, so we again used this approach (Figure 4a ). First, we established that NPM knockdown does not inhibit aspirin effects on the NF-kB pathway (degradation of IkB, nuclear/nucleolar translocation of RelA and repression of NF-kB-driven transcription) ( Figures  4b-d) . In fact, NPM depletion appeared to enhance aspirinmediated degradation of IkBa and nuclear/nucleolar translocation of RelA (Figures 4b and c) . In contrast, annexin V apoptosis assays indicated that depletion of NPM blocked the apoptotic response to the agent (Figure 4e ). These data were again confirmed using Mitotracker assays ( Figure 4f ). We found that aspirin induced a significant decrease in the number of cells showing active mitochondria (dye uptake) in cells transfected with control siRNA, but that this response was significantly abrogated in cells transfected with siRNA to NPM (Figures 4f and g ). Taken together, these data indicate that NPM is required for the apoptotic effects of this model stimulus of the NF-kB pathway and that this requirement lies downstream of nucleolar translocation of RelA. 25 In contrast to effects on cytoplasmic and nuclear levels of NPM, aspirin had a minimal effect on total levels of the protein (Figure 4a ).
Nucleolar targeting of
Taken together, the above data suggest that aspirin causes the cellular redistribution of NPM. They also suggest the intriguing possibility that nucleolar translocation of RelA is responsible for this redistribution. To test this hypothesis, we initially utilized the NF-kB inhibitor, pyrrolidine dithiocarbamate (PDTC), which we have shown blocks aspirin-induced degradation of IkBa and cytoplasmic to nuclear/nucleolar translocation of NF-kB/RelA. 13 Here, we found that it also blocks aspirin-induced cytoplasmic accumulation of NPM ( Figure 6a ). To further confirm the importance of NF-kB in stress-mediated relocalization of NPM, RelA was depleted using siRNA. We obtained efficient knockdown of RelA on siRNA transfection and found that depleting RelA did not significantly affect the abundance of NPM (Figure 6b ). However, we found that the nuclear-cytoplasmic relocalization of NPM, observed in response to aspirin in cells transfected with control siRNA, was completely abrogated in cells transfected with siRNA to RelA (Figures 6c and d) .
These data indicated that stimulation of the NF-kB pathway/ RelA is required for relocalization of NPM to the cytoplasm. To determine whether nucleolar translocation of RelA is required, we utilized the nucleolar-deficient mutant, GFP-RelADNoLS. First, we established that the wild type (WT) and mutant proteins expressed comparably ( Figure 7a ) and confirmed that GFP-RelAWT translocates to the nucleolus in response to aspirin, while GFP-RelADNoLS remains nucleoplasmic, excluded from nucleoli ( Figure 7b ). In keeping with nucleolar RelA causing relocalization of NPM, we found that aspirin induced a time-dependent decrease in nuclear levels, and a parallel increase in cytoplasmic levels, of NPM in cells constitutively expressing GFP-RelAWT, but not in cells constitutively expressing GFP-RelADNoLS (Figure 7b ). These data were confirmed using live cell imaging, which again indicated that expression of GFP-RelADNoLS blocked aspirin-induced cytoplasmic redistribution of NPM (Figure 7c ).
To further establish the relationship between nucleolar translocation of RelA and cytoplasmic redistribution of NPM, we utilized the RelA nucleolar targeting vector (GFPNoLS RelA). We found that, although only a proportion of cells express the GFP-tagged proteins, transient transfection with GFP-
NoLS
RelA induced a significant increase in total cytoplasmic levels of NPM, compared with transfection with GFPNoLS or GFP-RelA (Figures 7d and e) . Anti-GFP western blot analysis indicated that this difference was not due to differences in expression levels of the fusion proteins (Figure 7d ).
Nuclear export is required for the apoptotic effects of nucleolar targeting of RelA. Previous studies demonstrated NPM is exported from the nucleus via the RelA is not associated with repression of NF-kB-driven transcription. SW480 cells were transfected with the specified GFP-tagged vectors along with the 3 Â kB ConA, NF-kB-dependent, luciferase reporter construct and a pCMVb control plasmid. NF-kB activity was measured 48h after transfection and levels relative to b-galactosidase activity determined. The mean ± S.E. is shown. N ¼ 3 Scale bars throughout ¼ 10 mm. The P-values shown in panels (a, c, e and g) are compared with GFP-
RelA and are derived using a Student's t-test Nucleolar RelA-NPM-BAX: a novel pathway to apoptosis N Khandelwal et al RAN-exportin-1 (CRM1p) pathway. 26 Therefore, to determine the relevance of the cytoplasmic relocalization of NPM with regard to the apoptotic effects of nucleolar RelA, we utilized the CRM1p specific inhibitor, leptomycin B (LMB).
This inhibitor had no effect on aspirin-induced nucleolar accumulation of RelA (data not shown and Stark and Dunlop 13 ). However, pretreatment with LMB blocked aspirin-mediated nucleolar-cytoplasmic translocation of RelA is not associated with modulation of NF-kB-driven transcription. The 3 Â kB ConA, NF-kBdependent, luciferase reporter construct and pCMVb control plasmid were transfected along with the specified GFP expression vectors. Mean NF-kB activity, relative to b-galactosidase activity, is presented ± S.E. N ¼ 3 Figures 8a and b) . Similar results were obtained using the GFP-
RelA construct. LMB blocked the cytoplasmic relocalization of NPM and apoptosis mediated by expression of this protein (Figures 8c and d) . Taken together, these data provide a very strong indication that nuclear export of NPM is required for the apoptotic effects of nucleolar targeting of RelA.
NPM interacts with BAX following nucleolar translocation of RelA. One mechanism by which cytoplasmic NPM has been shown to influence apoptosis is by chaperoning the pro-apoptotic protein, BAX, to the mitochondria. 24, 27 As a number of stimuli that induce nucleolar translocation of RelA are known to require BAX for their pro-apoptotic activity, we next examined this pathway to nucleolar RelA-mediated apoptosis.
Immunocytochemical analysis demonstrated that BAX accumulates in punctate cytoplasmic foci in response to aspirin (Figure 9a ). These foci colocalized with the mitochondrial marker, heat shock protein 60 (HSP60), suggesting that BAX accumulates at the mitochondria after aspirin treatment (Figure 9b 5d-f) . In keeping with a role for NPM in chaperoning BAX to the mitochondria, overexpression of NPM enhanced aspirin-mediated mitochondrial accumulation of BAX (compare transfected and non-transfected cells in Figure 9d ). In addition, siRNA-mediated knockdown of NPM (confirmed by western blot analysis (Figure 4a) ) abrogated this effect (Figure 9e) , and aspirin-mediated permeabilization of the outer mitochondrial membrane (Figures 4f and g ). Immunoprecipitation assays demonstrated that aspirin induces a specific interaction between NPM and BAX (Figure 9f ). Furthermore, this interaction was blocked by RelA depletion, confirming a role for RelA in this process (Figure 9g Taken together, these data provide compelling evidence that nucleolar translocation of RelA causes the cytoplasmic relocalization of NPM and consequently, mitochondrial accumulation of BAX and apoptosis (Figure 10f ).
Discussion
NF-kB is a critical regulator of the apoptotic process and can act as both a pro-and anti-apoptotic factor.
1,2 Although the anti-apoptotic function of NF-kB has been well characterized, the mechanisms that underlie its pro-apoptotic activity have yet to be fully elucidated. Previous studies indicate that in response to cell stress, NF-kB promotes apoptosis through the nucleolar accumulation of RelA. 13, 29 Here, we demonstrate that RelA actively stimulates a nucleolar pathway to initiate apoptosis (Figure 10f ). These data identify a novel, NF-kB regulated, pro-apoptotic pathway and a new mechanism by which RelA functions to induce apoptosis, independent of its effects on NF-kB transcriptional activity.
We initially used a viral NoLS-RelA fusion protein to show that targeting RelA to the nucleolus induces apoptosis (Figure 2 ). We then established that the nucleolar phosphoprotein, NPM, is required (Figure 3) . We also established that NPM is required for the apoptotic effects of a model stress stimulus of the NF-kB pathway and that this requirement lies downstream of nucleolar translocation of RelA (Figure 4 ). NPM has previously been shown to act as a co-activator of NF-kB-driven transcription. 23 However, here we found that the role of NPM was independent of NF-kB transcriptional activity (Figures 2-4) . The most documented apoptotic pathway regulated by NPM is the p53 pathway. 30 However, we have previously demonstrated that aspirin-mediated apoptosis does not require p53. 31 Taken together, these data suggest that RelA directly modulates a p53 independent, NPM-dependent nucleolar pathway to mediate apoptosis.
Although shuttling of NPM from the nucleolus to the nucleoplasm and cytoplasm is well documented, the mechanisms that govern this relocalization are poorly understood. 32, 33 On the basis of the following observations, we propose that stimulation of the NF-kB pathway/nucleolar translocation of RelA is one mechanism that drives the cytoplasmic redistribution of NPM. First, kinetic studies demonstrated a direct association between translocation of RelA to the nucleolus, a decrease in nuclear/nucleolar NPM and a corresponding Our model suggests that stress-induced nucleolar translocation of RelA mediates apoptosis by causing the nucleolar protein, NPM, to relocate to the cytoplasm, bind to BAX and chaperone BAX to the mitochondria. Nucleolar RelA-mediated repression of NF-kB-driven transcription may enhance this route to apoptosis by causing decreased expression of Bcl-xl, which inhibits BAX trafficking. See discussion for more details increase in cytoplasmic levels of the protein ( Figure 5 ). Second, blocking stimulation of the NF-kB pathway using a chemical inhibitor (PDTC) and RelA depletion, blocked the cellular re-distribution of NPM ( Figure 6 ). Third, blocking nucleolar translocation of RelA, by expressing GFP-RelAD NoLS, blocked cytoplasmic accumulation of NPM (Figure 7) . Finally, and most convincingly, expression of GFPNoLS RelA, which specifically targets RelA to the nucleolus, caused relocalization of NPM to the cytoplasm (Figure 7 ). In keeping with our proposal, UV-C radiation has previously been shown to induce both nucleolar translocation of RelA, 13, 21 and cytoplasmic relocalization of NPM. 24 It will now be extremely interesting to identify the pathway by which nucleolar RelA causes the re-distribution of NPM. RelA has previously been shown to bind to the nucleolar protein, LXXLL/leucine zipper containing ARF-binding protein (LZAP). 34 This is of interest as LZAP also binds p14 ARF , 35 which retains NPM in the nucleolus. 30 Therefore, one possibility is that RelA binding to LZAP in the nucleolus disrupts an LZAP, p14 ARF NPM complex, thus releasing NPM from this compartment. In addition to protein binding, NPM localization is regulated by posttranslational modifications such as ubiquitinylation and sumoylation. 22, 36 Therefore, another possible mechanism by which RelA may cause its relocalization is by facilitating modulation of its post-transcriptional modification state. In support of this suggestion, we found that aspirin and GFPNoLS RelA expression induced modified (high molecular weight) forms of NPM in the cytoplasm (data not shown). Furthermore, RelA has previously been shown to directly bind NPM. 23 These possible mechanisms of nucleolar RelA-mediated NPM relocalization are currently under investigation.
Our data suggest that on RelA-mediated relocalization to the cytoplasm, NPM initiates apoptosis by chaperoning the pro-apoptotic protein, BAX, to the outer mitochondrial membrane. This mechanism of NPM-mediated apoptosis has previously been shown in response to UV-C radiation and staurosporin in vitro and ischemic reperfusion in vivo. 24, 27 However, ours is the first study to link this cytoplasmic apoptotic pathway to stimulation of NF-kB signaling ( Figure 10 ). Lindenboim et al. 33 have suggested that, contrary to NPM transporting BAX to the mitochondria, BAX is required for apoptotic stimuli-mediated nuclear to cytoplasmic relocalization of NPM. Here, we found that knockdown of BAX had no effect on nucleolar RelA-mediated cytoplasmic accumulation of NPM (data not shown), suggesting that in the pathway we have unraveled, BAX is not acting as an NPM chaperone but that NPM acts as a BAX chaperone.
Our data showing depletion of NPM blocks aspirinmediated apoptosis, but not the effects of the agent on repression of NF-kB-driven transcription, may suggest that nucleolar RelA-mediated repression of NF-kB transcriptional activity is of no consequence. However, one of the antiapoptotic proteins that is regulated by NF-kB is Bcl-xl, which acts by inhibiting BAX-mediated permeabilization of the outer mitochondrial membrane. 37 Therefore, one may imagine a model whereby in response to stress agents, nucleolar translocation of RelA promotes BAX-mediated disruption of mitochondria both by causing a decrease in levels of Bcl-xl and by inducing cytoplasmic relocalization of NPM (Figure 10f ).
In summary, use of a vector that targets RelA to the nucleolus has allowed us to systematically dissect a novel pathway by which RelA promotes apoptosis in response to cellular stress. Although we used aspirin as a model stressinducing agent, it must be emphasized that data presented here, showing nucleolar RelA in non-stimulated cell populations (Figure 1b) and elsewhere, 13, 21, 24 support the idea that this pathway is physiologically relevant and is general to stress response. These novel findings provide opportunities for additional research on RelA's function within the nucleolus. Furthermore, these findings have major ramifications for the design of new therapies that target RelA to this cellular compartment, which could be used in a variety of pathologies.
Materials and Methods
Cell culture, reagents. Cell culture and reagents have been described elsewhere. 13, 21, 25 Plasmids. pEGFP-RelA, pEGFP-HIV-rev and the three enhancer CONA (3 Â kB ConA-Luc) plasmids have been described elsewhere. 13, 20, 38 pEGFPNoLS and pEGFP-
NoLS
RelA were constructed by PCR subcloning the rev nucleolar targeting signal from pEGFP-HIV-rev in frame with the C-terminal of EGFP in either EGFP-C1 (Clonetech, Mountain View, CA, USA) or pEGFP-RelA. DsRed versions of these plasmids were generated in the same manner using DsRed-C1 and DsRed-RelA as backbone vectors. DsRed-NPM was supplied by P Roussel (University of Paris). GFP-NPM was generated by subcloning NPM from this vector into pEGFP-C1 (Clonetech), in fusion with GFP. The pCMV-b-galactosidase plasmid is commercially available (Promega, Southhampton, UK).
Transfections, RNA interference and reporter assays. Plasmid/ siRNA transfections and NF-kB reporter assays were carried out as previously described.
13,21 siRNAs used were: NPM: 5 0 -UGAUGAAAAUGAGCACCAG UUTT-3 0 , 39 BAX: 5 0 -AAGGUGCCGGAACUGAUCAGA-3 040 and RelA: 5 0 -GCUGA UGUGCACCGACAAG-3 0 . 8 For studies involving both siRNA and plasmid transfection, cells were transfected with plasmid 24 h after transfection with siRNA.
Live cell imaging, immunoblotting, immunocytochemical staining, apoptosis assays and Mitotracker assays. Live cell imaging, immunoblotting, immunocytochemical staining and apoptosis assays were carried out as described previously. 13, 21, 25 All were performed on the adherent cell population, apart from apoptosis assays, which included floating (dead) cells. The Mitotracker assay was carried out as per the manufacturer's instructions and uptake of the mitochondrial dye analyzed by fluorescent microscopy. The following primary antibodies were used for immunoblot analysis: rabbit anti-RelA(C-20), rabbit anti-GFP, rabbit anti-BAX (N20), mouse anti-B23 (NPM) (all from Santa Cruz, Santa Cruz, CA, USA), IkBa (gift from Professor R Hay (Dundee) and mouse anti-actin (Sigma, Dorset, UK). Immunocytochemistry was performed using antibodies against RelA (C20, Santa Cruz), NPM (Santa Cruz) UBF (Santa Cruz), BAX, (Santa Cruz) and Hsp60 (Sigma).
Fluorescence imaging and analysis. Images were captured using a Coolsnap HQ CCD camera (Photometrics Ltd, Tuscon, AZ, USA) Zeiss Axioplan II fluorescent microscope, 63 Â Plan Neofluor objective, a 100 W Hg source (Carl Zeiss, Welwyn Garden City, UK) and Chroma 83 000 triple band pass filter set (Chroma Technology, Bellows Falls, UT, USA). Image capture and analysis were performed using scripts written for IPLab Spectrum 3.6 in house. For each panel, a constant exposure time was used. The percentage of cells showing annexin V binding, nucleolar RelA, uptake of Mitotracker dye or punctate BAX was determined in at least 200 cells from at least five random fields of view in three independent experiments, or as specified.
Immunoprecipitation. Immunoprecipitation assays were performed using 500 mg whole cell lysate as previously described. 27 Rabbit polyclonal anti-BAX (Santa Cruz) was used to immunoprecipitate the appropriate protein. Rabbit IgG (pre-immune serum) was used as a control. Complexes were resolved by SDS polyacrylamide gel electrophoresis then analyzed by western blot analysis.
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